Robert J. May

Array ( [id] => 1148226 [patent_doc_number] => 06774227 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-10 [patent_title] => 'Therapeutic uses of factors which inhibit or neutralize MIF activity' [patent_app_type] => B1 [patent_app_number] => 08/738947 [patent_app_country] => US [patent_app_date] => 1996-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12226 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/774/06774227.pdf [firstpage_image] =>[orig_patent_app_number] => 08738947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1256310 [patent_doc_number] => 06667293 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-23 [patent_title] => 'Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response' [patent_app_type] => B1 [patent_app_number] => 08/527126 [patent_app_country] => US [patent_app_date] => 1995-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 7897 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/667/06667293.pdf [firstpage_image] =>[orig_patent_app_number] => 08527126 [rel_patent_id] =>[rel_patent_doc_number] =>)